AMBI to acquire Nutrition 21 for $10 mil. plus stock at closing under tentative agreement.
This article was originally published in The Tan Sheet
Executive Summary
AMBI ACQUISITION OF NUTRITION 21 FOR $10 MIL. PLUS STOCK at closing was announced as an agreement in principle June 13. Tarrytown, N.Y.-based AMBI (formerly Applied Microbiology) said the acquisition of the San Diego-based trace minerals and dietary supplements developer and marketer would help it create a presence in the dietary supplements market and build on the "foundation" initiated by the recent launch of the Cardia Salt Alternative for the dietary management of hypertension.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning